Evidence map›Paper›PMID 38003418›Full record

ArticleInternational journal of molecular sciences2023

A Disintegrin and Metalloproteinase with Thrombospondin Motifs 4 Regulates Pulmonary Vascular Hyperpermeability through Destruction of Glycocalyx in Acute Respiratory Distress Syndrome.

Makiko Konda, Masahiro Kitabatake, Noriko Ouji-Sageshima, Rei Tonomura, Ryutaro Furukawa, Shota Sonobe, Chiyoko Terada-Ikeda, Maiko Takeda, Masahiko Kawaguchi, Toshihiro Ito

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Makiko KondaDepartment of Immunology, Nara Medical University, Kashihara 6348521, Japan.
Masahiro KitabatakeDepartment of Immunology, Nara Medical University, Kashihara 6348521, Japan.
Noriko Ouji-SageshimaDepartment of Immunology, Nara Medical University, Kashihara 6348521, Japan.
Rei TonomuraDepartment of Immunology, Nara Medical University, Kashihara 6348521, Japan.
Ryutaro FurukawaDepartment of Immunology, Nara Medical University, Kashihara 6348521, Japan.
Shota SonobeDepartment of Immunology, Nara Medical University, Kashihara 6348521, Japan.
Chiyoko Terada-IkedaDepartment of Diagnostic Pathology, Nara Medical University, Kashihara 6348521, Japan.
Maiko TakedaDepartment of Diagnostic Pathology, Nara Medical University, Kashihara 6348521, Japan.
Masahiko KawaguchiDepartment of Anesthesiology, Nara Medical University, Kashihara 6348521, Japan.
Toshihiro ItoDepartment of Immunology, Nara Medical University, Kashihara 6348521, Japan.
Nara Medical University · JP

Funding

Japan Society for the Promotion of Science JP20K09310Japan Society for the Promotion of Science JP21K08162
6 · The paper itself

Abstract

Acute respiratory distress syndrome (ARDS) has no specific and effective treatment, and there is an urgent need to understand its pathogenesis. Therefore, based on the hypothesis that molecules whose expression is upregulated in injured pulmonary vascular endothelial cells (VECs) are involved in the pathogenesis of ARDS, we conducted a study to elucidate the molecular mechanisms and identify target factors for treatment. Primary human lung microvascular endothelial cells (HMVEC-Ls) were stimulated with lipopolysaccharide (LPS) or poly (I:C) and analyzed via a microarray to identify target genes for ARDS. We found that a disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS4) was induced in murine lung VECs in an LPS-mediated ARDS model. Elevated ADAMTS4 was also observed by the immunostaining of lung samples from ARDS patients. The suppression of ADAMTS4 by siRNA in VECs ameliorated LPS-stimulated vascular permeability. The impairment of the cell surface expression of syndecan-1, a marker of the glycocalyx that is an extracellular matrix involved in vascular permeability, was dramatically inhibited by ADAMTS4 suppression. In addition, the suppression of ADAMTS4 protected against LPS-induced reductions in syndecan-1 and the adherens junction protein vascular endothelial cadherin. These results suggest that ADAMTS4 regulates VEC permeability in ARDS and may be a predictive marker and therapeutic target for ARDS.

Indexed as

Endothelial CellsRespiratory Distress SyndromeAnimalsDisintegrinsGlycocalyxHumansLipopolysaccharidesLungMetalloproteasesMiceSyndecan-1ThrombospondinsDisintegrinsLipopolysaccharidesMetalloproteasesSyndecan-1ThrombospondinsADAMTS4ARDSendothelial cellsglycocalyxvascular permeability

Identifiers

PMID38003418
PMCPMC10671186
OpenAlexW4388635696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.